Parvovirus B19 Qualitative PCR Test
Understanding Parvovirus B19 Infection
Parvovirus B19 is a common viral infection that primarily affects children, causing the characteristic “slapped cheek” rash of Fifth Disease. However, this virus poses significant health risks for specific populations, including pregnant women, immunocompromised individuals, and those with blood disorders. Our Parvovirus B19 Qualitative PCR test represents the gold standard in molecular diagnostics for detecting active viral infection with unparalleled accuracy and sensitivity.
What Does This Test Detect?
The Parvovirus B19 Qualitative PCR test specifically identifies the presence of Parvovirus B19 DNA in peripheral blood samples. Unlike antibody tests that measure immune response, this PCR-based method directly detects the viral genetic material, providing definitive confirmation of active infection. The test utilizes advanced End Point PCR technology to amplify and identify even minute quantities of viral DNA, making it exceptionally reliable for early diagnosis.
Key Detection Capabilities:
- Active Parvovirus B19 infection confirmation
- Early detection before antibody development
- Quantitative assessment of viral load
- Monitoring treatment effectiveness
- Identification of persistent infections
Who Should Consider This Test?
Several patient populations benefit significantly from Parvovirus B19 Qualitative PCR testing. Early detection is particularly crucial for individuals at risk of complications.
Primary Candidates Include:
- Pregnant Women exposed to Parvovirus B19 or showing symptoms
- Immunocompromised Patients with HIV, cancer, or transplant recipients
- Individuals with Blood Disorders including sickle cell disease and thalassemia
- Healthcare Workers with potential exposure
- Children and Adults with unexplained arthritis or joint pain
- Patients with Persistent Anemia of unknown origin
Symptoms Warranting Testing:
- Characteristic “slapped cheek” facial rash
- Lacy red rash on trunk and limbs
- Fever, headache, and runny nose
- Joint pain and swelling (especially in adults)
- Unexplained fatigue and malaise
- Anemia symptoms in susceptible individuals
Benefits of Parvovirus B19 Qualitative PCR Testing
Choosing our advanced PCR testing methodology provides numerous advantages over traditional diagnostic approaches.
Key Benefits:
- Early Detection: Identifies infection before antibody development
- High Accuracy: 99% sensitivity and specificity rates
- Rapid Results: 2-3 day turnaround time
- Definitive Diagnosis: Confirms active versus past infection
- Pregnancy Safety: Critical for managing fetal infection risks
- Treatment Guidance: Informs appropriate medical interventions
- Peace of Mind: Provides clear answers for concerned patients
Understanding Your Test Results
Interpreting your Parvovirus B19 Qualitative PCR results is straightforward with proper medical guidance.
Possible Results and Their Meanings:
- Positive Result: Indicates active Parvovirus B19 infection requiring medical management
- Negative Result: Suggests no current active infection detected
- Inconclusive Result: May require retesting or additional diagnostic methods
Your healthcare provider will interpret these results in the context of your symptoms, medical history, and clinical presentation. Positive results typically warrant close monitoring, especially in pregnancy or immunocompromised states, while negative results provide reassurance about the absence of active infection.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $126 |
| Regular Price | $162 |
| Test Name | Parvovirus B19 Qualitative PCR |
| Turnaround Time | 2-3 Days |
| Sample Type | Peripheral Blood |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas. Our state-of-the-art laboratories in New York, Los Angeles, Chicago, Houston, Phoenix, and other key cities ensure consistent, reliable results nationwide. Each facility maintains the highest standards of quality control and employs certified laboratory professionals dedicated to accurate diagnostic testing.
Pre-Test Instructions and Requirements
For most patients, the Parvovirus B19 Qualitative PCR test requires a doctor’s prescription. However, prescription requirements do not apply to individuals undergoing surgery preparation, pregnancy-related testing, or those planning international travel. The test involves a simple blood draw using an EDTA Vacutainer (2ml), with no special preparation or fasting required beforehand.
Take Control of Your Health Today
Don’t leave your health to chance. Early detection of Parvovirus B19 infection can prevent serious complications and guide appropriate treatment. Our advanced PCR testing provides the definitive answers you need for informed healthcare decisions.
Ready to schedule your test? Call us now at +1(267) 388-9828 or book your appointment online. Our knowledgeable staff is available to answer your questions and help you take the next step toward better health.
With convenient locations nationwide and rapid 2-3 day results, there’s no reason to delay this important diagnostic evaluation. Trust the experts at General Genetics Corporation for accurate, reliable Parvovirus B19 testing you can count on.
